These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26796902)

  • 41. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.
    Bryant LJ; Coster G; Gamble GD; McCormick RN
    Int J Pharm Pract; 2011 Apr; 19(2):94-105. PubMed ID: 21385240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the paradigm of community pharmacy practice expected to shift due to COVID-19?
    Nadeem MF; Samanta S; Mustafa F
    Res Social Adm Pharm; 2021 Jan; 17(1):2046-2048. PubMed ID: 32565052
    [No Abstract]   [Full Text] [Related]  

  • 43. The Role of Pharmacists in the Opioid Epidemic: An Examination of Pharmacist-Focused Initiatives Across the United States and North Carolina.
    Reynolds V; Causey H; McKee J; Reinstein V; Muzyk A
    N C Med J; 2017; 78(3):202-205. PubMed ID: 28576963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community pharmacy-based point-of-care testing: A case study of pharmacist-physician collaborative working relationships.
    Bacci JL; Klepser D; Tilley H; Smith JK; Klepser ME
    Res Social Adm Pharm; 2018 Jan; 14(1):112-115. PubMed ID: 28082033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Pharmacists as Immunizers in North Carolina.
    Trotta K
    N C Med J; 2017; 78(3):206-207. PubMed ID: 28576964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.
    Eid DD; Meagher RC; Lengel AJ
    Consult Pharm; 2015 Aug; 30(8):459-62. PubMed ID: 26260642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacists' experience of conflict in community practice.
    Austin Z; Gregory PA; Martin JC
    Res Social Adm Pharm; 2010 Mar; 6(1):39-48. PubMed ID: 20188327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restructuring supervision and reconfiguration of skill mix in community pharmacy: Classification of perceived safety and risk.
    Bradley F; Willis SC; Noyce PR; Schafheutle EI
    Res Social Adm Pharm; 2016; 12(5):733-46. PubMed ID: 26642961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishing pathways for access to pharmacist-provided patient care.
    Schommer JC; Doucette WR; Planas LG
    J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disruptive innovation in community pharmacy - Impact of automation on the pharmacist workforce.
    Spinks J; Jackson J; Kirkpatrick CM; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(2):394-397. PubMed ID: 27283243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linking pharmacists to the delivery of public health services.
    Strand MA; Davidson KM; Schulze N
    J Am Pharm Assoc (2003); 2017; 57(6):742-746. PubMed ID: 28951135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measuring organizational flexibility in community pharmacy: Building the capacity to implement cognitive pharmaceutical services.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Res Social Adm Pharm; 2011 Mar; 7(1):27-38. PubMed ID: 21397879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems.
    Tucker R; Stewart D
    Int J Pharm Pract; 2015 Dec; 23(6):390-8. PubMed ID: 25689029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients' perceptions of a pharmacist-managed weight management clinic in a community setting.
    O'Neal KS; Crosby KM
    Res Social Adm Pharm; 2013; 9(1):129-36. PubMed ID: 22695218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?
    Jacobs S; Schafheutle EI; Jee SD; Elvey R; Hassell K; Noyce PR
    Res Social Adm Pharm; 2013; 9(2):166-77. PubMed ID: 23517658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating influences on current community pharmacy practice at micro, meso, and macro levels.
    Hermansyah A; Sainsbury E; Krass I
    Res Social Adm Pharm; 2017; 13(4):727-737. PubMed ID: 27530306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.